Financial position remains strong
In today’s year-end report, Nolato reports sales for the fourth quarter of 2011 of SEK 734 million (864). Operating income (EBITA) was SEK 48 million (63) and the EBITA margin was 6.5% (7.3). Nolato Medical’s sales totalled SEK 230 million (235), operating income amounted to SEK 28 million (28) and the EBITA margin was 12.2% (11.9). “Excluding currency conversion effects, Nolato Medical’s sales were in line with the previous year,” says Hans Porat, President and CEO of Nolato. “Product sales during the fourth quarter developed in line with the market, while sales within projects fell